High HCV Response Rates With Daclatasvir/AsunaprevirHigh HCV Response Rates With Daclatasvir/Asunaprevir

A combination of daclatasvir plus asunaprevir yielded high rates of sustained virological response (SVR) in treatment-naive patients with hepatitis C 1B infection, including those with cirrhosis, in a multinational phase III trial. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news